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Summary
Illegal dietary supplementation with b2-agonists has been shown to increase protein
deposition and decrease fat accretion in domestic animals. In poultry the metabolic and
endocrine responses to b2-agonists are not fully elucidated. In this trial the effects of
dietary clenbuterol (1 p.p.m.) and cimaterol (1 p.p.m.) on muscle composition and
endocrine response of male broiler chickens were studied. Dietary clenbuterol induced a
slight, but in general not significant, improvement of zootechnical performances and
carcass yields. Chemical composition of muscle was not influenced by dietary treatments,
even if a slight improvement of protein content was observed in treated groups. No effects
on fatty acid composition of meat were detected. Both clenbuterol and cimaterol
treatments caused a downregulation in testicular androgen receptors and in pulmonary,
cardiac and central nervous system b-adrenergic receptors.
Introduction
In veterinary therapy b2-adrenergic agonists have been used as bronchodilators in the
treatment of pulmonary diseases and as tocolytic agents. However, due to their
metabolic effects, b2-adrenergic compounds are illegally used as repartitioning agents to
improve the performance of meat-producing animals. In fact, the long-term adminis-
tration of high dosages (20–30 times the therapeutic dose) induces an increase in protein
content and a decrease in fat deposition (Fiems, 1987; Yang and McElligott, 1989).
Nevertheless, illicit treatments cause the presence of residues in edible tissues with
possible risks for consumers and can induce changes in target organs of treated animals
(Re et al., 1997).
Although b2-agonists stimulate lipolysis and inhibit lipogenesis in adipose tissue or liver
(Yang and McElligott, 1989), chicken adipocytes have been shown to be quite
insensitive in vitro to b-adrenergic stimulation (Re et al., 2000). In general, the effects
induced in birds are less pronounced than in mammals and seem to be more evident in
animals either very young or very old (Buttery and Dawson, 1987). The response of birds
to administration of partitioning agents widely vary according to the compound, the way
of administration, the dose, the duration of treatment, the sex and the age of animals
(Dalrymple et al., 1984; Lamming, 1987).
The aim of this research was to investigate the influence of dietary clenbuterol and
cimaterol on carcass composition and on b-adrenergic and androgen receptor concentra-
tions in target organs of broiler chicken.
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Materials and methods
Fifty-four male broiler chickens (Ross 508), 36 days old, were divided into three
homogeneous groups, randomly assigned to three experimental groups and fed isoenergetic
and isonitrogenous diets. Experimental animals were fed for 21 days with a standard diet
containing placebo (group 1, control), 1 p.p.m. of clenbuterol (group 2) and 1 p.p.m. of
cimaterol (group 3), respectively. The basal diet was a pelletted finisher diet containing
705 g of maize, 245 g of soya bean meal, 20 g of calcium biphosphate, 10 g of soya bean oil,
8 g of mineral and vitamin premix and 5 g of calcium carbonate per kg of dry matter (DM;
chemical composition per kg DM: metabolizable energy 12.9 MJ, crude protein 190 g,
ether extract 43 g, ash 44 g, water 120 g). The composition of mineral and vitamin premix
per kg was: retinol 30 000 U.I., cholecalciferol 7500 U.I., alphatocopheril-acetate 100 mg,
Cu 40 mg, Na 250 mg. Animals were housed in light–temperature-controlled room sited in
the authorized Experimental Farm (C.I.S.R.A.) of the Faculty of Veterinary Medicine of
the University of Torino, Italy. Feed and water were provided ad libitum. Individual body
weight and feed intake were weekly recorded to calculate the feed conversion ratio (FCR).
At the age of 57 days birds were fasted overnight and, after anaesthesia, were killed by
cervical dislocation. Eviscerated and plucked carcasses were weighed after removal of the
head, neck, feet and abdominal fat to obtain ready-to-cook carcasses.
Carcasses (n ¼ 18 per treatment) were stored in a cool chamber at 0–4 C until the next
day when carcass yield and pH of breast and thigh were evaluated. The m. pectoralis major
of right side (n ¼ 10 per treatment) was vacuum-packed and immediately frozen ()20 C)
and then analysed to determine the chemical composition as follows: moisture and ash by
oven method, protein by Kjeldhal selenium catalyst method (AOAC, 1990) and total lipids
(Folch et al., 1957); values are expressed as percentage of fresh matter basis.
The m. pectoralis major of left side (n ¼ 5 per treatment) was stored as the right one
until fatty acid analysis was performed. The fatty acid profile of diets and breast samples
were determined by capillary gas chromatography. Total lipids were extracted according to
Folch et al. (1957) and methyl esters of fatty acids were prepared by the methylation
procedure of AOAC (1990) and analysed by means of a gas chromatograph (Perkin-Elmer
8700; Perkin-Elmer, Norwalk, CT, USA) fitted with a flame ionization detector and
equipped with a 60-m fused silica capillary column. The operating conditions of the gas
chromatograph were as follows: injector temperature 250 C; initial oven temperature
180 C for 1 min, rate of 4 C/min up to 225 C, final oven temperature 225 C for
30 min; detector temperature of 270 C.
Immediately after slaughtering, tissue samples (n ¼ 18 per treatment) of heart, lung,
brain and testicles were collected from each animal and frozen ()80 C) until they were
homogenized to obtain cytosol and plasma membranes by fractioned ultracentrifugation.
Briefly, frozen tissue samples were homogenized in ice-cold buffer (50 mm Tris–HCl,
1 mm EDTA, 12 mm thioglycerol, 10 mm sodium molybdate, 10% glycerol; pH 7.4). The
homogenates were then filtered through a double layer of cheese-cloth and centrifuged at
3000 g for 20 min at 4 C. The supernatants were centrifuged at 105 000 g for 45 min at
4 C and the resulting supernatants (cytosolic fractions) were used for the measurement of
androgen receptors (An-R) (Re et al., 2001). The resulting pellets (membrane fractions)
were suspended using a sonicator in the incubation buffer (75 mm Tris–HCl, 25 mm
MgCl2; pH 7.4) at 4 C, diluted to a final concentration of 2 mg protein per millilitre and
used for the determination of b-adrenergic receptors (b-AR) (Re et al., 1995). Protein
concentrations were measured according to the method described by Lowry et al. (1951).
Androgen receptors and b-AR concentrations were measured using binding assays as
described previously by Re et al. (1993) and by Re et al. (1999). For the measurement of
b-AR concentrations, aliquots of heart, lung and brain membrane (200 lg) were incubated
in triplicated for 1 h at 37 C with increasing concentrations (0.06–4.00 nm) of high-
affinity, non-selective b-AR antagonist ()) [3H]CGP 12177 in a total volume of 200 ll of
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incubation buffer. Non-specific binding was measured in the presence of 100 lm
isoprenaline. Incubations were stopped by the addition of 2 ml of ice cold-buffered saline
(154 mm NaCl, 50 mm Tris–HCl; pH 7.4), and the resulting mixtures were immediately
filtered under vacuum over pre-soaked Whatman GF/C filters. The filters were then
washed with 3 · 4 ml of ice cold-buffered saline to remove free radioactivity, solubilized
in 4 ml of scintillation fluid (Filter-Count; Canberra Packard, Groningen, the Netherlands)
and the radioactivity was measured for 2 min using a b-counter (Tri-Carb 1600 TR,
Canberra Packard) at an efficiency of 60% (Re et al., 1999). The equilibrium dissociation
constants (Kd) and the maximum number of binding sites (Bmax), expressed as nanomolar
values and femtomoles of specifically bound ()) [3H]CGP 12177 per milligram of
membrane protein, respectively, were calculated by Scatchard analysis (Scatchard, 1949)
using a computer program (GraphPad, Prism; Institute for Scientific Informatics, San
Diego, CA, USA).
For the measurement of An-R concentrations, aliquots of cytosol (200 ll) were
incubated overnight in triplicated at 4 C with 50 ll of increasing concentrations of
[3H]mibolerone (0.13–2.6 nm). In order to avoid possible binding of mibolerone to
glucocorticoid receptors, 100 nm triamcinolone acetonide was added to each incubation
tube. After absorption of free hormones on dextran-coated charcoal and precipitation,
200 ll of the supernatant were added to 4 ml of scintillation liquid (Pico Fluor, Canberra
Packard) and counted by scintillation spectrometry as described above for b-AR assay. The
Kd (nm) and Bmax (fmoles of specifically bound hormone per milligram of cytosol protein)
were calculated as described above.
Data were analysed by one-way analysis of variance (anova), the Tukey test was
performed to split differences between groups (SPSS, 1997).
Results
Growth performance and carcass yields were slightly influenced by dietary administration
of b2-agonists (Table 1). Mean values were in general higher for the group treated with
clenbuterol. Data of feed intake and FCR were not submitted to statistical analysis because
they represent a global data for each group.
Chemical composition of breast muscle (Table 2) was affected by dietary treatment with
regard to moisture only, showing the highest value of moisture in both treated groups
(p < 0.05). A moderate, but not significant, increase of protein content in treated groups
was observed. Fatty acid composition of breast muscle was not affected by treatments
(Table 3).
Table 1. Growth performances, carcass yields and pH (n = 10) (mean ± SEM)
Control Clenbuterol Cimaterol p
Final body weight (g) 2755.94 ± 92.29 2827.83 ± 81.76 2739.65 ± 84.82 0.27
Daily feed intake (g)1 173.36 167.04 164.70 –
FCR (35–57 days)1 2.5 2.3 2.4 –
Carcass weight (g) 1979.43 ± 58.41 2064.42 ± 62.11 1939.04 ± 80.49 0.41
Carcass yield (%) 70.95 ± 1.10 72.11 ± 0.33 72.43 ± 0.75 0.37
Breast weight (g) 434.13 ± 19.27 481.53 ± 19.58 435.14 ± 22.56 0.18
Breast yield (%) 21.83 ± 0.56 23.24 ± 0.36 22.45 ± 0.53 0.14
Thigh weight (g) 290.94 ± 8.85 309.43 ± 9.84 281.74 ± 52.89 0.05
Thigh yield (%) 14.69 ± 0.21 14.98 ± 0.18 14.53 ± 0.13 0.02
Breast pH24h 5.86 ± 0.11 5.82 ± 0.04 5.80 ± 0.10 0.75
Thigh pH24h 6.16 ± 0.0.08 6.17 ± 0.09 6.16 ± 0.09 0.77
1 For each group
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Dietary administration of clenbuterol induced significant decreases in b-AR concentra-
tions in heart (p < 0.001), lung (p < 0.05), brain (p < 0.001) and of An-R levels in testicles
(p < 0.001) (Table 4).
In the same way, cimaterol induced significant downregulation of b-AR concentrations
in heart (p < 0.01), lung (p < 0.05), brain (p < 0.01) and of AnR in testicles (p < 0.001)
(Table 4).
Table 2. Chemical composition of breast meat (% on fresh matter basis) (n = 10) (mean ± SEM)
Control Clenbuterol Cimaterol p
Moisture 71.71 ± 2.91 73.14 ± 1.87* 73.04 ± 1.90* 0.02
Crude protein 22.93 ± 0.66 23.66 ± 0.53 23.60 ± 0.85 0.15
Lipid 1.38 ± 0.27 1.29 ± 0.12 1.39 ± 0.21 0.14
Ash 1.18 ± 0.10 1.20 ± 0.05 1.22 ± 0.11 0.72
* p < 0.05
Table 3. Fatty acid composition of diets and breast meat (% of fatty acid acyl esters) (n = 5)
(mean ± SEM)
Diets Breast meat
pControl Clenbuterol Cimaterol Control Clenbuterol Cimaterol
14:0 0.69 1.00 0.89 0.64 ± 0.00 0.71 ± 0.12 0.63 ± 0.01 0.73
14:1 0.20 0.26 0.20 ND ND ND –
16:0 15.50 15.72 15.89 25.59 ± 0.12 25.50 ± 0.49 24.05 ± 0.52 0.04
16:1 2.07 1.90 1.99 6.48 ± 0.49 6.24 ± 0.22 6.22 ± 0.26 0.85
18:0 4.87 4.85 4.30 8.63 ± 0.42 9.24 ± 0.26 9.82 ± 0.55 0.18
18:1 28.37 28.68 28.87 35.04 ± 0.50 33.73 ± 0.73 33.65 ± 0.90 0.35
18:2 n6 45.83 44.96 45.01 15.90 ± 0.74 16.36 ± 0.24 16.15 ± 0.52 0.84
18:3 n3 2.45 2.62 2.73 0.67 ± 0.14 0.63 ± 0.01 0.60 ± 0.01 0.85
20:1 ND ND ND 0.53 ± 0.01 0.49 ± 0.01 0.63 ± 0.14 0.59
20:4 n6 ND ND ND 3.03 ± 0.49 3.38 ± 0.13 3.89 ± 0.52 0.38
SFA 21.07 21.57 21.17 34.86 ± 0.41 35.45 ± 0.52 34.50 ± 0.18 0.26
MUFA 30.64 30.84 31.07 45.53 ± 0.63 44.17 ± 0.61 44.87 ± 0.88 0.43
PUFA 48.28 47.58 47.75 19.61 ± 0.74 20.37 ± 0.24 20.63 ± 0.76 0.52
n3 2.45 2.62 2.73 0.67 ± 0.14 0.63 ± 0.01 0.60 ± 0.01 0.85
n6 45.83 44.96 45.01 18.93 ± 0.66 19.74 ± 0.25 20.04 ± 0.01 0.43
n3/n6 0.05 0.06 0.06 0.04 ± 0.01 0.03 ± 0.00 0.03 ± 0.00 0.74
ND, not detected; SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, poly-
unsaturated fatty acid




Heart 244 ± 10 137 ± 11*** 177 ± 18**
Lung 906 ± 16 728 ± 28* 721 ± 75*
Brain 393 ± 28 253 ± 21*** 259 ± 23**
An-R
Testicles 33 ± 2 8 ± 0.4*** 8 ± 0.3***
* p < 0.05; ** p < 0.01; *** p < 0.001
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The values of Kd for ()) [
3H]CGP 12177 and [3H]mibolerone were not significantly
affected by treatments in any of the examined tissue (Table 5).
The linearity of the Scatchard plots was demonstrated by the values of the correlation
coefficient (r > 0.9).
Discussion
Rehfeldt et al. (1997) showed that the enhancement of muscle growth in birds receiving
clenbuterol is realized through the hypertrophic response of muscle fibres, but not through
the formation of new fibres or the additional incorporation of myonuclei by satellite cell
proliferation. This mechanism may explain the moderate improvement of breast and thigh
muscle weight, especially observed in animals treated with clenbuterol. Dietary admin-
istration of b2-agonists induced a non-significant reduction in fat composition of breast
muscle, thus confirming that the lipolytic effects in poultry may be regulated by different
metabolic pathways (e.g. glucagon release enhancement) (Re et al., 2000). Moreover,
b2-agonists treatment did not influence the mechanism of captation of fatty acid by breast
muscle, as revealed by the fatty acid composition of meat, that did not change among the
three experimental groups.
Data obtained in the present study demonstrated that the dietary administration of
clenbuterol and cimaterol as partitioning agents induced a significant downregulation of
b-AR in the heart, lung and brain of treated animals. Similar results have been observed in
other species such as veal calves, which have been chronically treated with dietary
clenbuterol (Re et al., 1995, 1997). Long-term administration of b2-agonist in poultry
induced a significant downregulation of An-R, as previously observed in another study
regarding the effects produced by clenbuterol treatment on oestrogen and progesterone
receptor expression in the genital tract of female broiler chickens (Cerruti Sola et al.,
1996). Strikingly, this effect is not in line with those observed in the reproductive system of
mammals, such as veal calves (Re et al., 1995), rats (Re et al., 1993) and pigs (Dacasto
et al., 1994).
After long-term exposure to b-adrenergic compounds, a decrease of sensitivity has been
observed in several target tissues and it has been demonstrated that desensitization
processes are associated with a failure of b-AR structures that act prior to cAMP
production (Housdorff et al., 1989; Pitcher et al., 1992). beta-Adrenergic receptor
downregulation could be attributed to different mechanisms. Initially, long-term exposure
to an agonist enhances the sequestration of the receptor to a location that may be
represented by a vescicular pool. In this state, the receptor is accessible only to ligands in a
highly hydrophobic form. Subsequently, downregulation is induced by a variety of cellular
processes including enhancement of protein degradation and a destabilization of mRNA
encoding b-AR (Collins et al., 1992; Milligan et al., 1994). Moreover, as a binding assay
was used, in the present study, a possible occupation of ()) [3H]CGP 12177 binding sites
by clenbuterol should be considered as partially responsible for the reduction (Kenakin,
1993).
Table 5. Kd (nM) values (n = 18) (mean ± SEM)
Control Clenbuterol Cimaterol
b-AR
Kd (heart) 0.30 ± 0.05 0.28 ± 0.02 0.22 ± 0.04
Kd (lung) 0.70 ± 0.04 0.64 ± 0.03 0.60 ± 0.06
Kd (brain) 0.24 ± 0.04 0.24 ± 0.04 0.20 ± 0.02
An-R
Kd (testicles) 0.45 ± 0.09 0.30 ± 0.05 0.30 ± 0.03
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As far as the effects induced by dietary clenbuterol on the central nervous system (CNS)
b-AR are concerned, they could be related to some behavioural modifications (Gorman
and Dunn, 1993). For example, reduced food consumption (which is associated with
partitioning effects on animal carcass composition responsible for a significant improve-
ment of feed efficiency) could be ascribed to excess b2-adrenergic stimulation at the CNS
(Borsini et al., 1982; Ordway et al., 1987).
At present, the mechanism of An-R downregulation observed in the testicles of broilers
treated with b2-agonist still remains quite unclear. As clenbuterol is not able to bind
significantly to steroid hormones receptors (Re et al., 1995), probably, the regulation of
An-R may occur in an indirect way, possibly mediated by b-AR. This theory is supported
by the observation that the concomitant exposure to propranolol inhibits the regulation of
ER and PgR expression exerted by clenbuterol in the female reproductive system (Re et al.,
1993). This result suggests the hypothesis that adrenergic and steroid receptorial system
could share some cellular mechanism (e.g. cellular messengers, protein phosphorylation or
genome activation), which interfere mutually on their control processes as already
demonstrated in laboratory animals (Vivat et al., 1992).
Finally, repeated b2-adrenergic agonist exposure did not induce any significant
modification in Kd values for both b-AR and An-R in any tested tissues, thus confirming
that the treatment did not alter the affinity of the receptors for specific ligands, as
previously observed in poultry (Cerruti Sola et al., 1996), veal calves (Re et al., 1995,
1997), pigs (Dacasto et al., 1994) and rats (Re et al., 1993).
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